CTI Clinical Trial and Consulting Services

General information
CTI Clinical Trial and Consulting Services
Schillerstrasse 1/15
89077 Ulm, Baden-Württemberg

Contact person: Christiane Alexander, Business Development & Client Management
Company main phone: +49 (160) 4356834
Company main fax:  +49 (731) 40008429
Website:  https://www.ctifacts.com
Year founded:1999
Source of foundation:Subsidiary
Name of foundation source:CTI Clinical Trial and Consulting Services, USA
No. of employees: Worldwide:  1000
At this location:  200
Corporate description / mission:
CTI Clinical Trial and Consulting Services provides drug development services. CTI is conducting clinical trials with life-changing therapies in chronically and critically ill patient populations. The company offers clinical trials, drug and device development, medical education, healthcare communication, early phase development, and health outcomes research. 
State of ownership: Private / independent
Headquarters: No
  • Professional Services and Consulting
  • Drug development consulting
Primary therapeutic areas:
  • Congenital malformations, deformations and chromosomal abnormalities / medical genetics
  • Diseases of the blood and blood-forming organs & immune disorders / hematology / immunology
  • Diseases of the ear / otology
  • Diseases of the nervous system / neurology
  • Endocrine, nutritional and metabolic diseases / endocrinology
  • Infectious and parasitic diseases / infectiology / parasitology
  • Musculoskeletal system and connective tissue / Orthopedics
  • Neoplasms / cancer / oncology
Business model:
  • Research on contract basis
  • Service company
  • Subsidiary
Customer segments:
  • Large biotech & big pharma
  • Large medtech
  • Small biotech
  • Small medtech
  • Direct (own sales force)
Summary Products / Services / Technologies
Description of products:
Regulatory Consulting,
Clinical Trial Services PhI-IV,
Lab Services,
CRC - Phase I unit,
RWE Services, Market access, HTA.
Collaborations & Clients
Client portfolio (as relevant):
CTI is currently working on behalf of more than 200 sponsors from the biotech, pharma and medtech industry based in Europe, US, Asia-Pacific, and Latin America. CTI has successfully been a part of more than 100 new drug and device approvals through global regulatory agencies such as the FDA, EMA, and others, and has conducted more than 6000 successful, innovative and cost-effective projects.